Association between tTMB and clinical outcomes with pembrolizumab alone in PD-L1-positive advanced NSCLC in KEYNOTE-010 and -042

IMPALA results: Lefitolimod vs standard of care in metastatic colorectal cancer

AMG 510: A novel molecule targeting KRAS G12C mutant solid tumours

MEDIOLA: Olaparib and durvalumab for germline BRCA-mutated metastatic breast cancer

Blood first assay screening in patients with ALK positive NSCLC

Phase III study of veliparib with carboplatin and paclitaxel in HER2-negative advanced/metastatic gBRCA-associated breast cancer

CUPISCO: Identifying carcinoma of unknown primary patients according to ESMO guidelines

CheckMate 459: Safety and efficacy of nivolumab versus sorafenib as a first-line treatment in advanced hepatocellular carcinoma

Optimal timing of radiotherapy following radical prostatectomy

Safety and tolerability of AVB500 in platinum-resistant recurrent ovarian cancer

INVICTUS: Assessing the safety and efficacy of ripretinib in patients with advanced gastrointestinal stromal tumours

Using PARP inhibitors to improve quality of life for patients with metastatic breast cancer